Description
Alpha-amanitin: synthetic derivatives for applications in targeted therapy
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-04-01$405,452
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-04-01(start date) | $405,452 | — | Alpha-amanitin: synthetic derivatives for applications in targeted therapy |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2023-2024-Q1-00192 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,063,350 | FY2024 |
| 236-2022-2023-Q1-00092 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,139,850 | FY2023 |
| 236-2020-2021-Q4-00048 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $50,000 | FY2021 |
| 236-2020-2021-Q1-00182 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $167,056 | FY2021 |
| 236-2017-2018-Q4-00386 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $596,700 | FY2019 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q4-00034 · retrieved 2026-11-14.